| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Caspase-1|CASP-1|Interleukin-1 beta convertase(IL-1BC|Interleukin-1 beta-converting enzyme(ICE;IL-1 beta-converting enzyme|CASP1|IL1BC|IL1BCE |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human CASP1 (Caspase-1) is a molecular target commonly studied in metabolism research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of CASP1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of CASP1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
CASP1 (Caspase-1) may also be referenced as Caspase-1, CASP-1, and Interleukin-1 beta convertase(IL-1BC in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how CASP1 relates to energy homeostasis, glucose and lipid metabolism, insulin sensitivity and endocrine regulation, and adipose–liver crosstalk in metabolism research.
- Interpreting shifts in CASP1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
CASP1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Programmed cell death markers in COVID-19 survivors with and without sepsis
IF: 5.7 Journal: Frontiers in Immunology Author: Department of Transplant Immunology and Stem Cell Lab, Global Medical Education and Research Foundation, Hyderabad, India Cited Date: 2025-02-28
NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stress
IF: 5.6 Journal: Biochemical Pharmacology Author: Department of Health Sciences, University of Florence, Italy; National Institute for Cardiovascular Research (INRC), Bologna, Italy. Cited Date: 2025-12-19
Serum IL-1β as a Novel Predictor of No-Reflow in STEMI Patients Undergoing Primary PCI
IF: 4.1 Journal: Journal of Inflammation Research Author: Department of Cardiology, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, People's Republic of China. Cited Date: 2025-11-07
Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis
IF: 3.276 Journal: Immunology Letters Cited Date: 2021-05-06
Activation of NLRP3 inflammasome in patients with renal transplantation: relation to allograft dysfunction, inflammation, and renal fibrosis
IF: 0.8 Journal: Alexandria Journal of Medicine Author: Department of Internal Medicine (Nephrology and Transplantation Unit), Alexandria university, Alexandria, Egypt Cited Date: 2024-08-30
Effect of doxorubicin on Caspase-1/GSDMD-mediated pyroptosis in MCF-7 breast cancer spheroids
IF: Journal: Ege Journal of Medicine Author: Nigde Omer Halisdemir University Faculty of Medicine Department of Histology and Embryology Nigde-Türkiye Cited Date: 2025-12-26